Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Northwestern’s Cognitive Neurology and Alzheimer’s Disease Center Receives $8.6 Million Renewal
Campus News

Northwestern’s Cognitive Neurology and Alzheimer’s Disease Center Receives $8.6 Million Renewal

By Sarah PlumridgeAug 30, 2016
Share
Facebook Twitter Email
Marsel Mesulam, MD, is director of the Cognitive Neurology and Alzheimer’s Disease Center, which received a five-year, $8.6 million grant renewal from the National Institute on Aging.

The National Institute on Aging (NIA) has renewed funding for the Cognitive Neurology and Alzheimer’s Disease Center (CNADC), supporting an additional five years of research, and marking 25 years of continuous grant support.

The $8.6 million grant continues CNADC’s status as one of the nation’s 31 Alzheimer’s Disease Centers, a program established by the NIA to enhance research on Alzheimer’s disease and to find a way to cure and possibly prevent the disease.

Northwestern received the grant in in 1996 and since then has gone through a competitive renewal every five years since then.

“It’s been a remarkable process, I’m really looking forward to the next five years,” said Marsel Mesulam, MD, director of the CNADC.

According to Mesulam, what has made this center so successful is the establishment of CNADC as a combined effort across the university.

“We’ve been able to encourage collaborations across centers, departments and campuses. CNADC is an umbrella for more than 50 multidisciplinary faculty,” said Mesulam, also the Ruth Dunbar Davee Professor of Neuroscience and professor of Neurology.

The grant supports many of the research projects happening within the CNADC, and has supported several basic science accomplishments including the work of William Klein, PhD, professor of Neurology and at the Weinberg College of Arts and Sciences, Robert Vassar, PhD, professor of Cell and Molecular Biology, Linda Van Eldik, PhD, former professor of Cell and Molecular Biology and former associate director of the CNADC and the late Lester “Skip” Binder, PhD, professor of Cell and Molecular Biology.

Mesulam said the center has distinguished itself through research demonstrating that dementia can be caused by many diseases other than Alzheimer’s disease, especially frontotemporal degenerations. The center’s work on primary progressive aphasia (PPA), a gradual impairment of word finding and word usage, showed there are dementias where memory remains intact, with patients expressing difficulties in language, behavior or visuospatial skills. The CNADC is now a referral center for PPA and conducts unique clinical, research and psychosocial programs focusing on this condition.

Other projects the center grant supports include:

  • Emily Rogalski, PhD, research associate professor in the CNADC and Changiz Geula, PhD, research associate professor in the CNADC, working with “SuperAgers,” a group of people aged 80 years old or more with remarkable memory preservation.
  • Darby Morhardt, PhD, research associate professor in the CNADC, and her non-pharmacological interventions for increasing quality of life of patient’s Alzheimer’s disease and their families. One intervention is the buddy program, where first-year medical students are matched with patients.
  • Sandra Weintraub, PhD, professor of Psychiatry and Behavioral Sciences and of Neurology at the CNADC, is currently conducting clinical trials on a medication in individuals with no symptoms of memory loss, to observe if the medication decreases the risk of developing Alzheimer’s disease.

Over the next five years the CNADC plans to enlarge their research space and recruit new faculty members to continue to increase Northwestern’s role in the national effort.

“Alzheimer’s disease is not only an area of tremendous need, but an area of tremendous opportunity for studying degenerative diseases and issues related to aging, in addition to understanding more about how the human brain works,” Mesulam said.

Awards Neurology and Neuroscience Research
Share. Facebook Twitter Email

Related Posts

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Comments are closed.

Latest News

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220617_NM_0434
20220617_NM_0858
20220617_NM_0643
20220617_NM_0835
20220617_NM_0544
20220617_NM_0450
20220617_NM_0790
20220617_NM_0811
20220617_NM_0851
20220617_NM_0696
20220617_NM_0779
20220617_NM_0838

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.